This observation is very important because GLUT12 plays a role in high glucose-induced cell migration, and, therefore, according to the authors’ suggestion, it may be a new strategy for the diagnosis and therapy of breast cancer in patients with hyperglycemia, as is observed, for example, in diabetes mellitus [93]. Here, SLC2A12 is linked to breast cancer.